Explore the Future of Health Care Innovation
Are you seeking groundbreaking startups to invest in? Join Mike Partsch and Josh Carson at the JPM Annual Healthcare Conference this January to explore some of the cutting-edge companies in the WARF Ventures portfolio.
Algorithm-enabled service improving care for late-stage cancer. |
 Developing novel medications with precision drug delivery systems for children and adults with vascular anomalies.Pitch deck. |
|
 Device to improve arrhythmia diagnosis in the ICU. |
Developing sirtuin-activating therapeutics for neuroprotective indications. |
|
Highly accurate tests to aid in the diagnosis and monitoring of prostate cancer. |
Structure-based therapeutics discovery company pioneering a novel class of tumor-specific drug targets. |
|
Delivering AI-powered, cloud-based, non-invasive tumor insights through MRAI™ from routine MRI scans, enhancing cancer diagnosis, treatment planning and patient outcomes. |
Developing smart neurosurgical devices for the treatment of hydrocephalus and beyond. |
|
Enhancing the glymphatic system for brain health. |
Globally accessible, non-invasive and precise diagnostic tests for ovarian cancer. |
|
Drug discovery company using proprietary 3D human neural organoid platform to model and target neuroinflammation in Alzheimer’s Disease and epilepsy. |
Engineering synthetic phage therapeutics to treat bacterial diseases. |
|
AI-powered software and services accelerating theranostic drug development and providing personalized treatment options for patients worldwide. |